Lifeboat Foundation

For five years, several AT&T employees were conspiring with a Pakistani man to install malware on company computers so that man could unlock millions of smartphones subsidized by the carrier, according to federal investigators.

On Tuesday, the Justice Department unsealed an indictment against Muhammad Fahd for bribing AT&T employees at a call center in Washington state to pull off the scheme. According to the feds, Fahd allegedly paid more than $1 million in bribes to the AT&T employees during the conspiracy, which allowed him to fraudulently unlock more than 2 million AT&T phones from 2012 to 2017.

Fahd allegedly partnered with businesses that offered cell phone unlocking services in exchange for a fee. These unnamed business would then supply him with the IMEI numbers of the phones bound to AT&T’s network.

My regular readers appreciate the fact that NASA is partnering with a number of commercial space businesses to permanently expand the human frontier into cis-Lunar space. While $20 billion in federal funding drives NASA’s amazing programs, the agency doesn’t get that money without strong public support. NASA has also long been supported by the National Space Society, a group founded by Werner von Braun. I’m proud to represent NSS as their Vice President of Space Development and to have chaired their International Space Development Conference this year. I’m also a huge fan of the Moon Village Association, which is helping to pave an international path for lunar settlement. The Southern California Commercial Spaceflight Initiative, which I direct at USC, hosted both those groups in a fantastic event last year. I’m excited to note that we will bring in the Mars Society this fall. That organization, founded by Robert Zubrin, leads the push for our next step, colonizing the Red Planet. You may however, be less familiar with the small group of aspirational space visionaries already working on conquering the stars, or with Tau Zero, the foundation dedicated to achieving that most audacious goal.

E_News™ delivers the most urgent News of the Day that we find relevant to the main theme of EcstadelicNET such as a new, cutting-edge scientific research, technological breakthroughs and emerging trends. Some material may be fully or partially from outside sources. The Top Stories section, on the other hand, contains only original content written by affiliated authors. Take me to Top Stories.

All Biotechnology Business News Crypto News Digital Physics Neurotechnologies Press Releases Quantum Computing Space Exploration

Alex Vikoulov is a futurist, digital philosopher, independent scholar, media commentator, essayist, author of the 2019 book “The Syntellect Hypothesis: Five Paradigms of the Mind’s Evolution.” Lives in San Francisco Bay Area. http://amazon.com/author/alexvikoulov

1. The 4 main things happening in Hyperbaric oxygen treatment: 1.- A decrease of inflammation 2.- An increase in the amount of oxygen in circulation and reversing hypoxia. 3.- Stimulate the release of stem cells from the brain along with the bone-derived stem cells. 4.- Kill infection. Why it matters for regenerative and dementia treatment? Listen to Dr. Scott Sherr explaining in detail in http://www.mendelhaim.com/podcast/2. For more information on Dr. Scott’s work go to https://www.hyperbaricmedicalsolutions.com/integrative-hbot/scott-sherr.

2. Raising money for academic research is a hard point, according to all of my guests, but even when we talk about Hyperbaric treatment there is a lack of money and the number of chambers declines in u.s. In Israel by the way, the demand is increasing and it takes a few months waiting in lines to start getting the treatment, this can turn into a big business opportunity in my opinion as to the risk for such research on participants is not as big as other medical research.

3. Longevity investment is a relatively new field and is lack of a method to invest by, the Three criteria that Sergey Young from the Longevity Vision Fund examine before investing in new companies are 1- will the product be affordable to touch millions of people’s lives and not only help the rich. 2- Looking for sectors that enjoy the technological exponential development paste such as AI, early diagnostics, stem cells, warbles, and organ transplants. 3 — Network, if you are a new startup and trying to raise from The Longevity vision fund, question yourself before, Do you have partners that can market your product such as big pharma or health care chain or a big manufacturer, do you collaborate with the best academic institutes in the longevity research. Go listen to the full episode Mission Alpha with Sergey Young on http://www.mendelhaim.com/podcast/3

Seventy-five people filed into a Washington State Convention Center meeting room Wednesday to hear about the latest advancements in artificial intelligence. In a pitching session reminiscent of a speed-dating event, about 10 Northwest startups hurriedly shared their accomplishments and aspirations with Japanese investors eager to stoke business relationships.

Master of ceremonies Tom Sato, co-founder of Kirkland-based investing firm Innovation Finders Capital, lightened the mood by cracking jokes as he translated the English-speaking founders’ business plans into Japanese, cautioning the attendees that he faced a challenge: “I have to understand what the hell they’re talking about.”

The A.I. Age | This 12-month series of stories explores the social and economic questions arising from the fast-spreading uses of artificial intelligence. The series is funded with the help of the Harvard-MIT Ethics and Governance of AI Initiative. Seattle Times editors and reporters operate independently of our funders and maintain editorial control over the coverage.

Scientists at work in laboratory. Photo: Public domain via Wikicommons.

CTech – When chemistry Nobel laureate Michael Levitt met his wife two years ago, he didn’t know it would lead to a wonderful friendship with a young Israeli scientist. When Israeli scientist Shahar Barbash decided to found a startup with the aim of cutting down the time needed to develop new medicine, he didn’t know that a friend’s wedding would help him score a meeting with a man many want to meet but few do. But Levitt’s wife is an old friend of Barbash’s parents, and the rest, as they say, is history.

One of the joys of being an old scientist is to encourage extraordinary young ones, Levitt, an American-British-Israeli biophysicist and a professor at Stanford University since 1987, said in a recent interview with Calcalist. He might have met Barbash because his wife knew his family, but that is not enough to make him go into business with someone, Levitt said. “I got on board because his vision excited me, even though I thought it would be very hard to realize.”